elective neurosurgery treating unspecified brain conditions
Conditions
Brief summary
Incidence of adverse events and reactions according to following Adverse Events of Special Interest (AESI) in both study groups.
Detailed description
Duration of surgery, LOS, ICU LOS, 28-day mortality, descriptive analysis of the incidence of any adverse events and reactions, MAP, HR, SVV, number of episodes of hypotension, number of vasopressor administrations, Hemoglobin, plasma lactate level, Volume of blood loss, urinary output, number of administered units of packed RBC, number of subjects receiving transfusion, crystalloid and colloid solutions consumption, boluses of crystalloids
Interventions
Sponsors
Fakultni Nemocnice Brno
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of adverse events and reactions according to following Adverse Events of Special Interest (AESI) in both study groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of surgery, LOS, ICU LOS, 28-day mortality, descriptive analysis of the incidence of any adverse events and reactions, MAP, HR, SVV, number of episodes of hypotension, number of vasopressor administrations, Hemoglobin, plasma lactate level, Volume of blood loss, urinary output, number of administered units of packed RBC, number of subjects receiving transfusion, crystalloid and colloid solutions consumption, boluses of crystalloids | — |
Countries
Czechia
Outcome results
None listed